Raymond James Boosts Omega Healthcare Investors, Inc. Rating to 'Buy'

Raymond James has reinstated its buy rating for Omega Healthcare Investors, Inc. (NYSE:OHI) on June 17, 2026. The firm set a price target of $50, signaling confidence in the company's stock performance.

Other Institutional Activity in Omega Healthcare Investors, Inc.

Several other funds have adjusted their stakes in Omega Healthcare Investors. BlackRock, Inc. increased its holdings by 399,360 shares, bringing its total to 37,201,363 shares valued at about $1.63 billion. Vanguard Portfolio Management LLC established a new position with 27,123,117 shares worth approximately $1.19 billion. State Street Corp trimmed its stake by 44,776 shares, ending with 14,573,313 shares valued at $638.6 million. Cohen & Steers, Inc. reduced its position by 1,469,073 shares, retaining 11,977,541 shares worth $524.9 million. Meanwhile, Geode Capital Management, LLC added 412,183 shares, holding a total of 8,928,107 shares valued at $391.3 million.

Omega Healthcare Investors, Inc. Stock Down 0.2%

Shares of Omega Healthcare Investors, Inc. are trading at $45.5. The company has a market cap of $13.55 billion and a P/E ratio of 22.0. It has a beta of 0.576, indicating lower volatility compared to the market. The stock's 52-week range is between $35.7 and $49.33. Its 50-day moving average is $46.39, and the 200-day moving average is $44.62. The company has a current ratio of 0.563 and a quick ratio of 0.308, with a debt-to-equity ratio of 81.511.

Recent Earnings

Omega Healthcare Investors reported revenue of approximately $1.23 billion, with a revenue growth rate of 14.3%. The company posted an EPS of $2.07, achieving a net margin of 51.4% and a return on equity of 12.6%. The next earnings report is expected on July 30, 2026.

Dividend

Omega Healthcare Investors offers an annual dividend rate of $2.68, yielding 5.89%. The dividend payout ratio stands at 1.29.

Insider Buying and Selling at Omega Healthcare Investors, Inc.

Insider trading activity at Omega Healthcare Investors included purchases and sales by several insiders. On June 5, 2026, Kevin Jacobs acquired 6,125 shares at an average price of $43.67. On the same day, Barbara Hill sold 7,079 shares, while Stephen Plavin bought 4,424 shares.

Analysts Set New Price Targets

On June 17, 2026, Raymond James reinstated its buy rating for Omega Healthcare Investors with a $50 price target. Truist Securities maintained a hold rating with a $46 target on June 9, 2026. Wells Fargo also maintained a hold rating, setting a $49 target on June 1, 2026. UBS maintained a buy rating with a $54 target on May 13, 2026.

About Omega Healthcare Investors, Inc.

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust (REIT) based in Hunt Valley, Maryland. The company provides capital and financing to the long-term healthcare industry in the U.S. and the U.K., focusing on skilled nursing and assisted living facilities. As of September 30, 2025, Omega's portfolio includes 1,024 operating facilities across 42 states and the U.K./Jersey, managed by 88 operators. The company is led by CEO C. Taylor Pickett and employs 69 people.

Bottom Line

Raymond James's recent rating reinstatement for Omega Healthcare Investors, Inc. reflects a positive outlook with a $50 target. Investors closely monitor analyst ratings as they provide insights into potential stock performance. It's important to note that 13F filings and analyst ratings are backward-looking and may not represent the current position or future performance.